Divarasib

1 trends tracked about this subject — the full history, oldest to newest below.

↓ Cooling Business

Roche's new lung-cancer drug divarasib shows superior survival rates compared to rivals in late-stage trials, targeting the emerging oncology market.

6 sources 6 articles v 4 1h ago

\n \n \n

\n \n \n \n